MARISA NARVAEZ: Open Payments
NPI 1679175574 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,925 in 72 payments from 17 companies in 2025. Trend: 2023 $1,360 · 2024 $2,132 · 2025 $1,925
Food & beverage: $1,834Education: $91
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $353 |
| OPKO Pharmaceuticals, LLC | 16 | $275 |
| Novartis Pharmaceuticals Corporation | 5 | $193 |
| Ardelyx, Inc. | 10 | $186 |
| Travere Therapeutics, Inc. | 5 | $180 |
| Amgen Inc. | 4 | $168 |
| Mallinckrodt Hospital Products Inc. | 4 | $143 |
| Corcept Therapeutics | 1 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
Products named: FARXIGA, RAYALDEE, IBSRELA, KRYSTEXXA, ACTHAR, Filspari, Korlym, Fabhalta.
Industry payments across TX — which companies pay providers there.
